Jump to navigation links Jump to main content Jump to footer links

Welcome to the Investor Lab

Allied BioScience, a disruptive biotechnology company, is the world leader in continuously active antimicrobial coatings and has multiple peer-reviewed publications.

Founded in 2008, our products save lives and help protect businesses/economies by reducing the footprint of global infection caused by the transmission of microorganisms that people encounter in their daily lives.

home sw img

Rooted in Technical Innovation. Poised for Growth.

Allied BioScience’s lead product, SurfaceWise2™, is the first and only EPA-approved antimicrobial surface coating that continuously kills bacteria and viruses. It’s the outstanding result of more than a decade of research and development.

2008-2011
2012
2013
2014
2015
2016
2018-2019
2020
Previous

R&D Antimicrobial, residual surface coatings

2008-2011

Santa Monica Transit Study

2012

First hospital trial with 19 ICU beds

2013

Trail published in AJIC, Trademark secured

2014

Findings presented to the WHO, Geneva

Collaborated with Norocore cruise line for Norovirus study

2015

Methodist ICU Trails

2016
  • SW1 EPA Registration
  • NBA trial
  • NFL trial
  • Methodist Study
  • FDA meeting
  • BARDA meeting
  • Gates Foundation
  • CDC funding study
2018-2019
  • SurfaceWise2 EPA Emergency Exemption granted
  • medRxiv Publications
  • American Airlines commercial launch
  • Department of Defense Naval Pilot
  • SARs-CoV-2 Residual Study
  • Boeing Clean Airplane Program
  • Tray Table / Field Case Studies
2020
Next

10

Years
of innovation

+

1

GOAL:
superior safety

=

sw white logo

SurfaceWise2™: A One-of-a-Kind Product

product comparison n
sw sticker img

Here’s why SurfaceWise2 represents a unique investment opportunity, with all the underpinnings for explosive growth:

  • There’s a large unmet global need to prevent microbial disease
  • Our aggressive worldwide strategy is experiencing significant traction
  • Our rapidly scalable business model leverages existing networks and infrastructure, so there’s a virtually limitless supply of the product ready to deploy
  • Investors can expect highly favorable near-term profitability and cash flow generation
  • Allied BioScience is run by a best-in-class management and science team
Let’s connect! Find us on LinkedIn Twitter Facebook
See how our products perform in real-world environments.
Study: MedRxiv – A Continuously Active Antimicrobial Coating Effective Against Human Coronavirus 229E
Study: MedRxiv – A Continuously Active Antimicrobial Coating Effective Against Human Coronavirus 229E

See how the studied antimicrobial surface coating’s lasting effectiveness reduces the risk of surface transmission.

Learn More
Demonstrate HAI Reduction
Demonstrate HAI Reduction

Antimicrobial surface coating demonstrates persistent reduction of microbial burden and HAIs at two high-acuity hospitals.

Learn More
Study: Impact of a Novel Antimicrobial Surface Coating on Health Care
Study: Impact of a Novel Antimicrobial Surface Coating on Health Care

A study by the Infectious Diseases Society of America shows the studied antimicrobial surface coating affects steep declines in HAIs and environmental bioburdens in hospitals.

Learn More
Study: How to Stop Disease from Traveling
Study: How to Stop Disease from Traveling

The University of Arizona’s Department of Soil, Water and Environmental Science tests the effect of an antimicrobial surface coating on municipal buses.

Learn More
Hospital Surface Hygiene
Hospital Surface Hygiene

The Opportunity for Continuous Antimicrobial Protection Educational Case Study published in Healthcare Hygiene Magazine.

Learn More
Educational Case Study
Educational Case Study

Hospital Surface Hygiene: The Opportunity for Continuous Antimicrobial Protection Educational Case Study published in Healthcare Hygiene Magazine.

Learn More

Contact Us

Want to learn more about investment opportunities with Allied BioScience?
Contact SVP Bonnie Schmidt with inquiries.